Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3003752	u-bkvnh	— (—)	193	726	100.00%	Distribution not available
3003752	u-bkvnh	u/ml (—)	52	98	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic kidney disease

148

122.13

286.47

4.3

2.8

—

L04AA Selective immunosuppressants

141

89.31

268.66

4.0

3.0

—

Renal failure

153

80.06

257.60

4.2

2.8

—

All chronic kidney diseases

158

56.45

236.24

4.3

3.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

177

64.18

220.26

4.1

2.3

—

All kidney diseases

166

31.58

190.02

4.2

2.7

—

ILD medications: immunosuppressive drugs

196

262.74

186.51

4.1

1.1

—

L04AD Calcineurin inhibitors

181

269.54

178.03

4.1

6.6

—

First line medication for Crohn's disease

165

59.56

171.89

4.6

2.1

—

Renal tubulo-interstitial diseases

149

24.72

170.54

4.0

3.4

—

Glomerular diseases

41.75

164.63

4.2

4.5

—

Nephropathy related operations

158

272.38

155.36

4.4

3.7

—

Kidney transplant status

151

271.49

149.45

4.3

3.7

—

Dialysis, with operation codes

151

259.00

148.05

4.2

3.7

—

Azathioprine

36.26

137.84

5.7

3.6

—

ILD medications

180

122.24

132.50

4.4

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

170

119.10

126.54

4.3

1.1

—

Hypoplasia of dental enamel

55.64

119.97

7.0

6.0

—

Molar incisor enamel hypoplasia

38.08

117.49

7.0

6.1

—

L04AX Other immunosuppressants

101

15.58

116.92

5.4

2.6

—

Second line medication for Crohn's disease

102

15.26

116.81

5.4

2.5

—

Glomerulonephritis

41.86

116.24

5.3

5.4

—

Hypoplasia of dental enamel , including avohilmo

35.13

110.93

7.0

6.1

—

Care involving dialysis

116

150.25

109.89

4.0

4.3

—

Persons encountering health services for specific procedures and health care

135

13.98

106.41

3.9

3.7

—

Fever of other and unknown origin

18.45

106.12

4.0

2.1

—

Acute tubulo-interstitial nephritis

23.92

104.82

4.1

3.5

—

Nephrotic syndrome

56.38

104.01

5.8

6.7

—

Gingival hyperplasia

56.04

103.95

6.6

5.5

—

Dialysis

101

216.01

98.70

4.9

2.8

—

Diarrhoea and gastroenteritis of presumed infectious origin

11.52

88.96

4.6

3.0

—

Other disorders of kidney and ureter

47.72

88.87

3.9

4.2

—

Septicaemia

16.05

86.85

4.6

4.2

—

Hypertensive diseases (excluding secondary)

19.68

86.27

5.2

3.8

—

Antihypertensive medication - note that there are other indications

106

18.77

85.63

5.5

3.3

—

Other septicaemia

16.54

83.84

4.3

—

Explicit Sepsis

14.71

82.97

4.6

—

Hypertensive diseases

107

14.41

81.98

4.9

3.1

—

Hypertension

107

14.40

81.96

4.9

3.1

—

Other bacterial diseases

112

9.67

77.92

4.1

3.5

—

Intestinal infectious diseases

106

9.36

77.35

4.2

2.8

—

Other problems related to primary support group, including family circumstances

17.21

75.13

7.2

4.6

—

Dental caries

100.37

74.65

3.7

2.0

—

GASTRO-related operations

36.52

72.71

4.6

2.2

—

Any gastric operation

36.52

72.71

4.6

2.2

—

Other bacterial diseases

113

8.65

70.72

4.2

3.6

—

Extracorporeal dialysis

99.52

70.32

3.6

4.9

—

Cardiovascular diseases (excluding rheumatic etc)

11.41

68.82

5.1

4.3

—

Genitourinary diseases

19.22

68.64

5.9

3.7

—

Congenital malformations of the urinary system

19.03

68.41

4.4

6.3

—

Congenital malformations of the urinary system

19.01

68.39

4.4

6.3

—

Viral infections characterized by skin and mucous membrane lesions

9.76

64.95

4.8

4.2

—

Viral and other specified intestinal infections

14.46

64.63

6.0

3.7

—

Viral and other specified intestinal infections

12.84

62.04

5.9

3.9

—

Bacterial infection, other or unspecified

12.94

61.56

3.8

3.4

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

11.12

61.22

7.0

3.7

—

Other dialysis

89.05

60.65

5.1

4.8

—

Anaemias

34.72

59.62

4.7

5.0

—

Bacterial infection, other or unspecified

11.71

58.14

3.8

3.4

—

Cardiovascular diseases

10.89

57.80

5.3

4.6

—

Inflammatory bowel disease treatment related agents

111

7.23

56.99

5.0

2.6

—

Caries of dentine

101.08

56.16

2.8

2.3

—

Heart failure, not strict

10.06

53.19

2.6

3.9

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6.76

52.75

4.1

3.7

—

Molar incisor enamel hypoplasia, with caries

79.08

52.28

7.0

7.9

—

Dependence on enabling machines and devices, not elsewhere classified

+∞

52.05

6.2

0.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

15.23

50.22

3.1

5.6

—

Viral infections characterized by skin and mucous membrane lesions

116

6.34

48.73

4.2

3.6

—

Aplastic and other anaemias

11.56

48.72

3.6

3.2

—

Acute upper respiratory infections of multiple and unspecified sites

8.80

48.41

4.1

2.3

—

Certain infectious and parasitic diseases

13.83

47.78

3.8

1.9

—

Metabolic disorders

7.08

46.19

2.8

4.4

—

Other viral diseases

7.56

45.97

5.6

4.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

6.76

44.69

4.2

2.6

—

Disorders resulting from impaired renal tubular function

84.76

44.15

3.9

4.8

—

Other viral diseases

6.99

43.47

5.6

4.0

—

Gastrointestinal diseases

23.71

43.06

4.6

1.5

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

7.71

42.57

4.5

5.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

7.70

42.49

4.5

5.9

—

Care involving use of rehabilitation procedures

9.58

41.88

3.6

4.0

—

Implicit bacterial Sepsis

14.66

39.54

2.9

3.7

—

Implicit viral Sepsis

12.21

39.22

3.5

3.7

—

Bacterial Sepsis

11.00

38.98

3.6

3.8

—

Liquid cancers, helper endpoint

10.02

38.72

2.9

4.7

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

8.67

38.58

3.7

2.2

—

8.67

38.58

3.7

2.2

—

Congenital malformations, deformations and chromosomal abnormalities

101

6.23

38.46

3.7

4.0

—

Implicit Sepsis

7.81

38.37

2.8

3.6

—

Influenza and pneumonia

109

5.25

37.45

4.0

3.8

—

Other disorders of fluid, electrolyte and acid-base balance

15.74

37.15

3.5

4.3

—

Implicit Sepsis

7.44

36.97

2.9

3.5

—

Disorders of other endocrine glands

6.61

36.82

4.9

—

Glomerular disorders in diseases classified elsewhere

54.19

36.37

2.1

3.5

—

Implicit bacterial Sepsis

12.17

35.17

2.9

3.4

—

Infections, IBD-co-morbidities

17.92

34.58

2.9

5.4

—

Congenital malformations, deformations and chromosomal abnormalities

105

5.71

34.31

3.8

—

Excessive attrition of teeth

6.18

34.19

6.2

2.7

—

Condition for Implicit Sepsis (Organ dysfunction codes)

6.73

33.52

2.9

3.4

—

All influenza

8.94

33.27

4.7

5.2

—

Intestinal infectious diseases

5.44

32.00

3.8

2.6

—

Any reimbursement code in KELA

40.98

31.18

3.6

2.3

—

Cystic kidney disease

71.85

31.02

3.0

4.2

—

Cystic kidney disease

71.69

31.01

3.0

4.2

—

Other viral diseases, not elsewhere classified

6.77

30.80

6.3

4.5

—

Codes for special purposes

6.41

30.53

3.4

3.7

—

Provisional assignment of new diseases of uncertain etiology

6.41

30.53

3.4

3.7

—

Nausea and vomiting

7.06

30.47

5.1

—

Bronchitis

5.70

29.66

3.5

2.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

5.75

28.36

2.9

3.4

—

Other reaction to severe stress, and adjustment disorders

7.33

28.35

3.8

2.9

—

Other viral diseases, not elsewhere classified

5.94

28.26

6.2

4.4

—

General examination and investigation of persons without complaint and reported diagnosis

10.01

28.11

4.6

1.4

—

Covid-19 confirmed case

7.77

27.59

3.2

—

Pneumonias (Asthma/COPD co-morbidities)

116

4.46

27.56

3.7

4.1

—

Diabetic nephropathy

52.88

26.99

1.1

1.2

—

Diseases of peritoneum

62.42

26.95

3.7

2.0

—

Other and unspecified anaemias

8.35

26.38

3.4

3.3

—

Pneumonia, organism unspecified

105

4.61

26.12

4.0

3.8

—

Zoster [herpes zoster]

8.37

26.07

2.3

—

Viral warts

7.68

25.89

5.2

3.9

—

Anomalies of dental arch relationship, including avohilmo

7.35

25.83

6.3

3.9

—

Other anaemias

8.12

25.79

3.4

3.2

—

General symptoms and signs

6.00

25.63

3.2

2.0

—

Implicit viral Sepsis

21.84

25.57

3.6

4.7

—

Viral Sepsis

21.84

25.57

3.6

4.7

—

Erosion of teeth , including avohilmo

7.06

25.39

6.0

3.2

—

All pneumoniae

124

4.15

25.30

3.7

4.0

—

Endocrine, nutritional and metabolic diseases

5.22

25.03

3.7

5.1

—

Diabetic nephropathy, excluding more controls

44.08

24.76

1.1

1.0

—

Other disorders of urethra and urinary system

6.08

24.44

4.1

3.2

—

Complications of medical and surgical care

5.47

23.81

2.6

3.0

—

Other cataract

10.98

23.42

3.9

2.8

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

104

4.87

23.29

5.8

4.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

127

3.98

23.23

3.8

4.0

—

Disorders of lens

7.29

23.19

3.0

2.2

—

Examination and observation for other reasons

9.31

23.14

4.4

1.2

—

Certain disorders involving the immune mechanism

8.55

22.74

5.2

3.8

—

Crowding of teeth, including avohilmo

6.63

22.71

7.1

5.6

—

Other special examinations and investigations of persons without complaint or reported diagnosis

8.65

22.61

4.0

1.4

—

Hypoplasia of dental enamel, prenatal

64.23

22.35

8.0

5.7

—

Certain infectious and parasitic diseases

9.31

22.31

4.0

1.8

—

Complications of surgical and medical care, not elsewhere classified

4.52

22.05

2.7

3.1

—

Other retinal disorders

6.36

21.97

1.6

2.7

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4.20

21.80

3.4

3.9

—

Acute upper respiratory infections

4.98

21.55

4.1

2.2

—

Otitis media, unspecified

7.55

21.17

5.2

5.3

—

Viral warts

17.90

20.83

5.5

5.7

—

Acute suppurative otitis media

5.96

20.58

5.8

3.9

—

Caries of enamel

4.27

20.38

4.6

2.6

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.73

19.67

2.5

3.1

—

Polycystic kidney disease

40.98

19.56

2.4

5.2

—

Persons encountering health services in other circumstances, wide

3.92

19.39

3.5

3.9

—

Medical observation and evaluation for suspected diseases and conditions

7.89

19.37

3.4

1.4

—

Other disorders of skin and subcutaneous tissue

5.06

18.91

2.7

3.3

—

Other diseases of hard tissues of teeth

12.08

18.73

5.1

1.9

—

COPD/asthma related infections

5.46

18.68

3.8

2.2

—

COPD/asthma/ILD related infections

5.46

18.68

3.8

2.2

—

Headache

6.13

17.74

3.8

2.1

—

Neoplasms

3.86

17.63

4.2

4.6

—

Hypoplasia of dental enamel, prenatal , including avohilmo

22.35

17.49

8.0

6.7

—

Speech and linguistic disorders, excluding more controls

6.90

17.24

6.9

5.1

—

4.55

17.20

3.9

2.0

—

Symptoms and signs involving the urinary system

4.32

17.11

3.8

3.5

—

Unspecified haematuria

6.83

16.85

4.3

3.1

—

Hypertension, essential

6.39

16.62

1.4

1.9

—

Disorders of choroid and retina

4.74

16.61

1.6

2.6

—

Diabetic retinopathy

9.18

16.19

1.3

1.2

—

Other heart diseases

5.47

15.95

4.5

4.4

—

Other acute lower respiratory infections

108

3.97

15.85

4.4

4.2

—

Certain conditions originating in the perinatal period

5.26

15.83

6.3

5.3

—

Other endocrine disorders

5.73

15.58

6.3

7.1

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

26.37

15.57

2.2

2.1

—

Other metabolic disorders

13.94

14.98

3.1

3.6

—

Suppurative and unspecified otitis media

4.70

14.89

5.5

3.5

—

Diseases of the eye and adnexa

3.87

14.64

4.1

4.2

—

Cytomegalovirus infection, IBD co-morbidity

36.74

14.48

3.4

4.4

—

Nonsuppurative otitis media

5.31

14.45

5.3

4.4

—

Personal history of other diseases and conditions

35.95

14.39

4.7

1.2

—

Disorders of lipoprotein metabolism and other lipidaemias

4.88

14.30

1.4

2.5

—

Melanocytic naevi

5.96

14.29

4.6

3.4

—

Persons with potential health hazards related to communicable diseases

109

3.82

14.22

4.9

4.8

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

19.16

14.20

1.8

2.8

—

Disorders of refraction and accommodation

4.28

14.16

6.8

4.8

—

Crossbite

4.81

14.10

7.0

6.5

—

Lack of expected normal physiological development

20.81

14.09

6.1

5.0

—

Heart failure and antihypertensive medication

27.50

13.90

3.4

1.2

—

Hypo-osmolality and hyponatraemia

23.65

13.72

3.6

4.4

—

Insulin, fast-acting (human)

12.04

13.55

1.2

3.0

—

Zoster [herpes zoster]

14.70

13.54

2.5

2.8

—

Type 1 diabetes

4.40

13.48

1.5

5.5

—

4.74

13.37

7.3

6.5

—

Symptoms and signs concerning food and fluid intake

21.15

13.30

7.4

4.2

—

Diabetic retinopathy, strict definition

14.98

13.25

1.2

—

Persons encountering health services for examination and investigation

6.27

13.20

3.1

1.4

—

Deep bite

4.55

13.03

6.7

6.2

—

Other disorders starting during childhood or adolecense, excluding more controls

6.24

12.89

8.3

5.5

—

Infections of the skin and subcutaneous tissue

131

3.40

12.89

4.3

4.1

—

Disorders of parathyroid gland

28.03

12.86

1.9

2.0

—

Sub-endpoint used in defining T1D endpoints

4.22

12.75

1.5

5.4

—

Anxiety disorders, excluding more controls

3.72

12.62

4.5

2.3

—

Hyperlipidaemia, other/unspecified

12.67

12.53

1.4

1.9

—

Hyperparathyroidism

31.69

12.48

1.9

1.2

—

Neurotic, stress-related and somatoform disorders

106

3.30

12.40

4.2

2.8

—

Anxiety disorders

106

3.29

12.32

4.2

2.8

—

Other pulmonary diagnosis

5.35

12.29

3.1

2.1

—

Malignant neoplasm

3.36

12.07

2.9

3.7

—

Diabetic retinopathy, excluding more controls

14.35

12.03

1.3

1.2

—

Malignant neoplasm, wide definition for exclusion

3.25

11.87

2.9

3.9

—

Insulin, fast-acting

4.14

11.74

1.4

5.3

—

4.57

11.64

7.5

6.7

—

Excluding asthma or asthma-COPD overlap

5.18

11.58

3.2

2.1

—

COPD differential diagnosis

5.18

11.58

3.2

2.0

—

ILD differential diagnosis

5.18

11.58

3.2

2.0

—

Insulin, fast-acting or short human

4.08

11.54

1.4

5.3

—

Diseases of middle ear and mastoid

3.66

11.51

4.6

3.0

—

Other diseases of urinary system

100

3.09

11.51

4.1

3.5

—

Osteopathies and chondropathies

4.03

11.49

2.9

3.8

—

Other bacterial intestinal infections

13.60

11.43

2.4

3.3

—

Bleeding

101

3.24

11.19

2.5

3.8

—

Presence of other functional implants

23.60

11.15

2.0

2.4

—

Statin medication

4.19

11.05

2.1

2.6

—

Disorders of psychological development

3.92

11.03

6.5

5.7

—

Other and unspecified tonsillitis

4.89

10.97

4.8

2.8

—

Coagulation defects, purpura and other haemorrhagic conditions

5.39

10.86

3.8

5.3

—

Diabetic maculopathy

23.60

10.78

1.1

1.2

—

Acute bronchiolitis

4.18

10.74

5.9

6.3

—

Vitreous haemorrhage

28.08

10.71

1.2

1.0

—

Diabetic maculopathy, excluding more controls

17.83

10.71

1.1

1.8

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

19.63

10.61

1.1

3.0

—

Short stature, not elsewhere classified

4.83

10.56

6.1

7.2

—

Polyneuropathies and other disorders of the peripheral nervous system

10.02

10.48

2.6

3.0

—

Tubulo-interstitial nephritis, not specified as acute or chronic

+∞

10.42

3.3

0.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.55

10.41

6.1

4.8

—

Cough

3.81

10.40

4.4

4.3

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

16.22

10.36

6.4

—

Other disorders involving the immune mechanism, not elsewhere classified

16.20

10.36

6.4

—

Hypermetropia

7.71

10.36

6.9

—

Other bacterial intestinal infections

10.57

10.25

2.4

3.1

—

Diseases of oral cavity, salivary glands and jaws

8.15

10.23

3.5

1.9

—

Agranulocytosis

13.12

10.14

5.7

3.4

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

14.82

10.03

7.4

6.5

—

Tooth eruption problems

4.06

9.93

5.1

5.0

—

Convulsions, not elsewhere classified

8.99

9.89

4.8

3.0

—

Tramadol

4.19

9.84

1.6

1.4

—

Acute sinusitis

4.63

9.81

3.4

1.8

—

Mycoses

5.01

9.55

4.2

3.6

—

Bacterial intestinal infections, IBD co-morbidities

8.65

9.26

2.4

4.0

—

Type 1 diabetes, wide definition

3.81

9.19

1.4

5.6

—

Dermatitis

3.36

9.08

4.2

3.2

—

Heart failure,strict

7.80

8.95

3.4

3.8

—

Any event in cancer register

2.85

8.85

3.0

3.6

—

Other and unspecified polyneuropathies, also in other diseases

12.52

8.85

1.9

2.3

—

Gout, FINNGEN

10.65

8.75

1.6

1.5

—

Dentofacial anomalies [including malocclusion]

3.19

8.70

5.3

2.2

—

Malaise and fatigue

4.88

8.64

2.2

2.4

—

Senile cataract

5.15

8.60

1.1

1.6

—

Oedema, not elsewhere classified

8.08

8.46

2.8

1.6

—

Other diseases of blood and blood-forming organs, wide

6.37

8.45

5.4

3.9

—

All influenza (not pneumonia)

7.32

8.42

5.3

5.4

—

Speech and linguistic disorders

3.51

8.38

6.8

5.9

—

Hernia

109

2.77

8.37

5.2

3.3

—

12.75

8.36

2.5

2.6

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

9.50

8.28

6.7

6.9

—

Melanocytic naevi of trunk

10.74

8.28

4.8

3.0

—

Irregular menses

4.48

8.21

2.5

1.9

—

Other and unspecified dermatitis

3.42

8.19

4.4

3.2

—

Non-Hodgkin lymphoma, all, including Hilmo

14.47

8.19

2.0

4.3

—

Otitis externa

4.21

8.18

6.3

4.5

—

Symptoms and signs involving the skin and subcutaneous tissue

115

2.98

8.17

3.5

3.8

—

Type 1 diabetes, wide definition, subgroup 1

3.68

8.14

1.1

5.5

—

Neurological diseases, wide definition

4.64

8.11

4.7

5.4

—

Stomatitis and related lesions

4.74

8.10

5.7

3.8

—

Erysipelas

4.67

8.09

1.3

1.6

—

Need for other prophylactic measures

11.73

8.07

7.1

6.3

—

Volume depletion

11.70

8.06

3.6

4.7

—

Peripheral artery operations in Hilmo

22.02

8.00

1.1

1.0

—

Heart failure, strict

4.49

7.90

3.4

2.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

5.41

7.85

1.9

3.6

—

Symptoms and signs involving the digestive system and abdomen

2.58

7.67

5.0

4.0

—

Diseases of pulp and periapical tissues and dental caries

3.78

7.59

4.5

3.9

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.73

7.57

8.0

5.7

—

Rare circulating lymphoid malignancy, including Hilmo

10.10

7.54

4.5

6.2

—

Gout

8.29

7.54

1.6

1.5

—

Insulin, combination of fast acting with intermediate-acting or long-acting

3.02

7.53

1.4

4.4

—

Acute bronchitis

3.31

7.51

3.4

4.6

—

Other strabismus

3.57

7.51

5.6

5.1

—

Disorders of vitreous body and globe

4.43

7.41

1.2

1.6

—

Other heart diseases, wide

127

2.46

7.41

4.1

3.7

—

Peripheral artery disease

7.52

7.40

1.1

1.4

—

All-cause Heart Failure

4.41

7.39

3.5

2.7

—

Enterocolitis due to Clostridium difficile

13.36

7.37

2.7

2.8

—

Type 2 diabetes, wide definition

3.45

7.32

1.2

1.3

—

Retinal haemorrhage

+∞

7.30

1.9

0.0

—

Other postsurgical states

+∞

7.29

6.0

0.0

—

Other medical care

6.48

7.29

3.2

—

Recurrent aphthous stomatitis , including avohilmo

6.81

7.27

5.9

4.5

—

Disorders of skin appendages

3.11

7.09

4.4

3.5

—

Invasive ventilation

12.04

7.07

6.5

5.0

—

Strabismus

3.17

7.06

5.3

5.2

—

Varicella [chickenpox]

10.06

7.03

4.4

5.2

—

Venous thromboembolism

4.44

7.02

1.7

1.5

—

Erysipelas

3.82

7.00

1.5

—

Congenital vesicoureteral reflux

14.32

6.96

7.5

6.5

—

Bacterial pneumoniae

3.92

6.89

3.3

—

Cystitis

2.85

6.88

3.4

3.5

—

Cellulitis

3.96

6.88

4.7

4.5

—

Hypothyroidism (congenital or acquired)

9.42

6.82

2.6

4.9

—

Lymphoid leukaemia

9.33

6.78

4.8

6.0

—

Open bite

4.27

6.75

5.5

6.7

—

Cerebrovascular diseases (FINNGEN)

9.01

6.64

2.4

1.8

—

Cutaneous abscess, furuncle and carbuncle

4.00

6.61

3.0

3.5

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

4.20

6.59

6.9

6.7

—

Acute pharyngitis

5.82

6.54

6.6

3.6

—

Diabetic neuropathy

9.97

6.50

1.1

1.2

—

Coronary atherosclerosis

4.08

6.50

1.1

1.4

—

Bacterial pneumonia, not elsewhere classified

3.89

6.49

3.2

3.1

—

Childhood asthma (age<16)

9.32

6.46

3.9

3.7

—

Childhood asthma (age<16), excluding more controls

9.32

6.46

3.9

3.7

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

7.11

6.42

4.1

1.3

—

Medullary cystic kidney disease, nephronophthisis

+∞

6.35

3.3

0.0

—

Diseases of the respiratory system

3.84

6.35

3.8

2.0

—

Insulin medication

2.75

6.32

1.4

4.3

—

Immunodeficiency with predominantly antibody defects

18.14

6.27

4.6

6.2

—

Other diseases of arteries and capillaries

18.04

6.26

2.0

1.8

—

Acute nephritic syndrome

+∞

6.26

3.5

0.0

—

Disorders of vitreous body

5.12

6.24

1.2

1.5

—

Dental caries, including avohilmo

3.16

6.21

4.3

3.4

—

Viral pneumonia

7.01

6.21

2.5

4.2

—

Hyperkinetic disorders, excluding more controls

5.08

6.19

6.8

5.0

—

Oxycodone

5.49

6.19

1.8

1.3

—

Otitis externa, unspecified

6.27

6.15

6.0

4.7

—

Asthma (only as main-diagnosis)

3.99

6.13

3.1

2.1

—

STROKE

3.78

6.07

1.7

2.6

—

Diseases of the skin and subcutaneous tissue

2.51

6.06

3.9

3.5

—

Immunodeficiencies

10.05

6.03

3.9

4.5

—

Diseases of arteries, arterioles and capillaries

3.33

6.03

1.4

1.9

—

Asthma (only as main-diagnosis), excluding more controls

3.94

6.01

3.0

2.1

—

Diseases of external ear

3.24

5.98

6.2

4.3

—

Glaucoma

4.17

5.94

1.6

1.7

—

Drug-induced polyneuropathy

15.38

5.93

3.7

6.7

—

Opioids

2.87

5.93

1.9

—

Varicella [chickenpox]

6.39

5.85

4.1

6.0

—

Exclusions for E4_PCOS_BROAD

3.19

5.85

6.1

5.6

—

Asthma

3.80

5.83

3.0

2.1

—

Asthma (mode)

3.75

5.79

2.5

2.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

123

2.23

5.79

2.9

4.3

—

Asthma, excluding more controls

3.78

5.78

3.0

2.1

—

Other disorders starting during childhood or adolescence

3.18

5.77

8.3

6.2

—

Bacterial pneumonia (organism specified)

3.11

5.75

3.2

3.5

—

Nutritional anaemias

3.27

5.75

4.4

3.5

—

Insulin, intermediate and long-acting

2.79

5.70

1.1

4.4

—

Other congenital malformations of the digestive system

3.60

5.70

6.2

7.0

—

Disorders of sclera, cornea, iris and ciliary body

2.96

5.67

2.5

2.9

—

Autoimmune diseases excluding thyroid diseases

124

2.20

5.64

2.9

4.3

—

Overjet

3.72

5.61

7.8

6.5

—

Hypothyroidism, levothyroxine purchases

8.17

5.59

2.5

4.9

—

Hypothyroidism and >3 levothyroxin purchases

8.17

5.59

2.5

4.9

—

Peripheral arterial reconstruction

12.87

5.57

1.1

1.0

—

Gingivitis and periodontal diseases

2.40

5.52

3.7

4.2

—

Other noninfective gastroenteritis and colitis

3.06

5.47

4.0

5.3

—

Intermittent heterotropia

4.87

5.42

5.9

7.2

—

Abnormal findings on examination of urine, without diagnosis

16.07

5.41

2.0

5.0

—

Distal bite

3.47

5.40

8.1

6.4

—

Non-ischemic cardiomyopathy

5.93

5.37

4.6

3.4

—

Used for control exclusion in common control thyroid runs

123

2.14

5.37

3.9

4.4

—

Iron deficiency anaemia

3.29

5.29

4.5

3.7

—

Non-follicular lymphoma

11.27

5.29

2.2

2.6

—

Actinic keratosis

7.84

5.25

1.0

1.1

—

Candidiasis

6.68

5.24

3.6

4.4

—

Other disorders of bone

5.01

5.24

3.5

2.8

—

Polycystic ovarian syndrome, consortium definition

3.26

5.23

2.5

1.9

—

Multiple myeloma

+∞

5.21

1.0

0.0

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

+∞

5.21

1.0

0.0

—

Tonsillectomy and adenotomy

123

2.26

5.16

5.5

4.3

—

Dental operations

4.33

5.13

3.1

1.4

—

Emotional disorders starting during childhood or adolecense, excluding more controls

5.79

5.11

5.4

—

Specific development disorders of scholastic skills

3.61

5.09

6.1

—

Covid-19 suspected case

3.75

5.08

4.8

3.4

—

Other disorders of bladder

13.35

5.07

1.1

1.8

—

Other embolism and thrombosis

13.35

5.07

2.0

2.2

—

6.47

5.07

1.2

1.5

—

Noninflammatory disorders of female genital tract

4.06

5.05

3.2

2.8

—

Congenital malformations and deformations of the musculoskeletal system

2.99

5.04

5.8

6.5

—

Skin changes due to chronic exposure to nonionizing radiation

7.25

5.02

1.0

1.1

—

Undetermined asthma

10.01

5.02

4.0

2.9

—

Undetermined asthma, excluding more controls

10.01

5.02

4.0

2.9

—

Disorders of gallbladder, biliary tract and pancreas

2.44

5.01

3.5

2.2

—

Inguinal hernia

2.62

5.01

6.2

3.3

—

Excessive, frequent and irregular menstruation

4.33

4.95

3.3

2.4

—

Herpesviral [herpes simplex] infections

5.00

4.93

4.1

2.4

—

Other benign neoplasms of skin

3.66

4.91

2.1

2.6

—

Atherosclerosis, excluding cerebral and coronary sclerosis

5.72

4.89

1.1

1.4

—

Congenital malformations and deformations of the musculoskeletal system

3.02

4.89

5.7

6.7

—

Bacterial, viral and other infectious agents

7.71

4.84

6.1

4.8

—

Polyuria

7.70

4.84

1.8

2.3

—

Gout, unspecified

9.01

4.78

2.1

1.7

—

Embedded and impacted teeth

2.79

4.72

4.8

4.4

—

Any death

3.01

4.71

1.7

2.1

—

All anxiety disorders

2.57

4.71

3.9

3.1

—

Other congenital malformations of the digestive system

3.10

4.57

6.2

6.9

—

Other necrotizing vasculopathies

14.03

4.57

3.4

2.6

—

Neuromuscular dysfunction of bladder

14.02

4.57

2.3

2.0

—

Benign neoplasm: Skin of other and unspecified parts of face

14.02

4.57

1.1

1.0

—

Special screening examination for other diseases and disorders

14.01

4.57

2.4

1.8

—

Herpesviral [herpes simplex] infections

8.19

4.56

5.3

2.1

—

Acute laryngitis and tracheitis

5.37

4.53

6.3

4.4

—

Diseases of the musculoskeletal system and connective tissue

2.19

4.52

4.6

5.2

—

Explicit bacterial Sepsis

10.01

4.51

6.6

6.0

—

Seborrhoeic keratosis

10.01

4.51

1.8

1.9

—

Any mental disorder

2.18

4.51

4.3

2.8

—

Keratitis

3.15

4.47

2.7

3.1

—

Complications of procedures, not elsewhere classified

2.59

4.47

2.2

3.0

—

Rash and other nonspecific skin eruption

6.68

4.46

5.2

5.3

—

Pain, not elsewhere classified

5.79

4.43

3.5

2.3

—

Viral pneumonia (unknown virus, not influenza)

7.52

4.35

2.8

4.7

—

Enlarged lymph nodes

7.51

4.35

4.8

2.4

—

Follow-up examination after treatment for conditions other than malignant neoplasms

5.06

4.34

2.4

1.3

—

Speech therapy

4.25

4.31

3.6

3.4

—

Bacterial, viral and other infectious agents

6.26

4.29

6.1

4.7

—

Visual disturbances and blindness

2.53

4.28

4.0

4.3

—

Abnormalities of breathing

106

2.14

4.26

3.3

3.5

—

Non-allergic asthma (mode)

6.19

4.25

4.9

2.9

—

Other diseases of lip and oral mucosa

3.04

4.23

4.9

2.9

—

Codeine

2.72

4.20

1.6

1.4

—

Other anxiety disorders

2.80

4.19

2.6

2.9

—

Gout, idiopatic and unspecified

6.93

4.16

2.1

1.5

—

Diseases of oesophagus, stomach and duodenum

115

2.08

4.13

1.8

3.7

—

Amblyopia ex anopsia

4.36

4.13

5.2

7.2

—

Benign neoplasms

109

2.07

4.12

3.7

3.3

—

Hypopituitarism

4.01

4.09

6.6

6.7

—

Non-allergic asthma (mode), excluding more controls

5.83

4.09

4.9

2.8

—

Thrombocytopenia, unspecified

8.02

4.06

6.0

—

Chronic pancreatitis

8.01

4.06

1.9

2.2

—

Pure hypercholesterolaemia

2.95

4.05

1.2

2.7

—

Abdominal and pelvic pain

2.08

4.05

5.0

4.0

—

Retention of urine

5.31

4.04

1.2

2.7

—

Respiratory and cardiovascular disorders specific to the perinatal period

2.68

4.04

7.0

6.8

—

Atrial fibrillation and flutter

6.49

4.03

1.2

1.9

—

Male infertility

10.03

4.01

2.3

1.7

—

Depression medications

7.18

4.01

3.5

4.6

—

Other and unspecified drugs and medicaments

10.02

4.01

3.3

2.3

—

Streptococcal septicaemia

10.02

4.01

7.3

5.6

—

Purpura and other haemorrhagic conditions

4.45

3.93

4.8

6.2

—

Osteoporosis

5.50

3.90

2.5

4.0

—

In situ neoplasms

4.78

3.86

1.3

1.1

—

Delayed milestone in childhood

2.76

3.85

6.4

7.6

—

Symptoms and signs involving the circulatory and respiratory systems

108

2.00

3.83

4.7

3.5

—

Diseases of the ear and mastoid process

105

2.01

3.81

4.0

2.5

—

Pruritus

6.01

3.81

2.1

2.9

—

Astigmatism

4.29

3.81

7.8

7.1

—

Autoimmune diseases

128

1.91

3.80

3.3

4.3

—

6-mercaptopurine

12.04

3.76

3.3

7.6

—

Diseases of the digestive system

2.59

3.75

2.4

3.8

—

Phlebitis and thrombophlebitis (not including DVT)

5.00

3.68

1.2

1.8

—

Hernia of abdominal wall

2.79

3.68

5.5

2.3

—

121

2.21

3.65

4.4

4.9

—

Pain (limb, back, neck, head abdominally)

2.06

3.60

4.6

4.3

—

Tooth agenesis EXCLUDE clefts and syndromes

4.02

3.59

5.0

6.4

—

Systemic connective tissue disorders

3.72

3.58

2.7

3.0

—

Haemolytic anaemias

7.81

3.56

7.3

4.9

—

Other disorders of adrenal gland

7.80

3.56

7.0

5.4

—

Other coagulation defects

7.79

3.56

2.3

3.7

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

7.79

3.55

3.3

3.0

—

Acute pancreatitis (for exclusion)

5.30

3.50

3.8

2.3

—

Use of pramipexole

6.16

3.50

1.4

2.5

—

Other and unspecified coagulation defects

10.02

3.50

1.8

4.0

—

Cardiomyopathy, other and unspecified

10.01

3.49

3.3

7.2

—

COPD-related respiratory insufficiency

10.01

3.49

1.0

—

Motor disorders, excluding more controls

4.22

3.44

6.4

—

Disease of hard tissues of teeth, NOS

4.80

3.43

1.6

1.9

—

Disturbance of activity and attention

2.60

3.41

6.8

5.1

—

Procreative management

2.21

3.41

4.8

5.3

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.65

3.37

2.8

2.9

—

Parasetamol

2.17

3.35

2.8

3.9

—

Coxibs

0.00

3.33

0.0

2.1

—

Noninfectious colitis NAS

3.64

3.28

2.0

4.6

—

Candidiasis

3.64

3.28

3.6

3.9

—

Other otitis externa (chronic)

8.59

3.26

4.7

3.1

—

Other skin changes

4.74

3.23

1.9

3.3

—

Gastroduodenal ulcer

6.35

3.17

1.7

2.0

—

Other diseases of the digestive system

2.96

3.13

3.2

3.8

—

Nerve, nerve root and plexus disorders

2.09

3.12

1.4

2.2

—

Injury of muscle and tendon at wrist and hand level

4.51

3.11

1.1

2.5

—

Acute pancreatitis

4.50

3.11

3.8

2.4

—

Chronic periodontitis, complicated

2.70

3.09

1.7

1.4

—

Psychiatric diseases

1.97

3.08

4.7

2.9

—

Chronic periodontitis, including avohilmo

2.15

3.07

1.5

1.8

—

Periodontitis

2.15

3.06

1.5

1.8

—

Melanocytic naevi, other sites/unspecified

7.51

3.05

2.5

4.0

—

Orchitis and epididymitis

5.01

3.05

3.4

3.8

—

Chronic gastritis

5.00

3.04

1.0

1.9

—

Acute lymphocytic leukaemia, including Hilmo

5.96

3.04

5.3

6.7

—

Acute lymphocytic leukaemia, helper endpoint

5.96

3.04

5.3

6.7

—

Acute lymphocytic leukaemia

5.96

3.04

5.3

6.7

—

Other CVD

5.83

3.02

2.6

—

GI-bleeding

2.89

3.02

3.2

3.7

—

Umbilical hernia

3.34

3.01

5.5

1.9

—

Cardiomyopathy

4.29

2.99

3.0

4.5

—

Other congenital malformations of upper alimentary tract

10.16

2.99

7.0

5.6

—

Amenorrhoea

10.01

2.98

3.0

3.4

—

Secondary uncertain malignant neoplasm

10.01

2.98

4.4

5.6

—

Chondropathies

3.85

2.97

4.3

2.8

—

Diaphragmatic hernia

3.85

2.97

1.3

1.6

—

Heart failure and coronary heart disease

3.71

2.96

2.6

3.0

—

Cardiac murmurs and other cardiac sounds

2.86

2.96

8.5

5.9

—

Fitting and adjustment of other devices

4.28

2.94

3.9

2.8

—

Emotional disorders and disorders of social functioning with onset specific to childhood

2.85

2.93

5.4

5.8

—

Ischaemic heart disease, wide definition

2.45

2.93

1.1

1.4

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

4.75

2.92

5.5

6.1

—

Malnutrition

4.74

2.92

4.5

6.5

—

Abscess of anal and rectal regions

4.71

2.91

1.3

4.6

—

Noninfective enteritis and colitis

108

2.13

2.88

3.9

4.7

—

Glaucoma suspect

3.71

2.87

1.8

1.5

—

Other infectious diseases

6.67

2.86

2.5

4.6

—

Misadventures to patients during surgical and medical care

6.67

2.86

2.5

1.0

—

Anxiety (asthma-related co-morbidities)

2.05

2.84

4.0

3.3

—

Disorders of synovium and tendon

2.50

2.80

3.0

2.3

—

Pain in limb

117

1.89

2.79

4.1

3.8

—

Asthma, unspecified (mode)

3.45

2.79

4.2

2.0

—

Asthma, unspecified (mode), excluding more controls

3.43

2.77

4.2

2.0

—

Acne

3.08

2.76

6.2

4.2

—

Contraceptive management

2.55

2.76

2.9

1.5

—

Hypotension

8.34

2.75

1.6

1.0

—

Unspecified privation

5.01

2.72

2.9

4.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

5.00

2.72

2.1

2.9

—

Nonischemic cardiomyopathy

5.00

2.72

1.6

5.1

—

Seborrhoeic dermatitis

6.01

2.70

4.3

4.6

—

Fracture of rib(s), sternum and thoracic spine

3.45

2.68

1.1

2.3

—

Specific development disorders of speech and language

2.50

2.66

8.0

6.3

—

Sequelae of external causes of morbidity and mortality

3.14

2.64

2.5

2.9

—

Disturbances of skin sensation

3.33

2.60

2.5

1.9

—

Mouth breathing

113

2.03

2.59

5.2

4.8

—

Mental retardation, excluding more controls

3.66

2.59

6.8

—

Other neurological diseases

2.14

2.59

2.1

2.8

—

Persons encountering health services in other circumstances

2.53

2.58

4.1

4.6

—

Sequelae with surgical and medical care as external cause

4.00

2.56

3.1

3.0

—

Mandibular retrognathia

3.05

2.55

9.2

5.7

—

Hypothyroidism, strict autoimmune

2.32

2.55

1.8

3.3

—

Other osteochondropathies

7.15

2.55

5.8

3.6

—

Other infectious diseases

7.15

2.55

2.8

3.4

—

Hypokalaemia

7.15

2.55

5.6

4.4

—

Bronchitis, not specified as acute or chronic

7.15

2.55

1.6

2.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

7.15

2.55

4.4

5.3

—

Other complications of surgical and medical care, not elsewhere classified

5.46

2.54

2.5

—

Budesonide

5.46

2.54

1.0

1.5

—

Infections with a predominantly sexual mode of transmission

2.85

2.53

1.4

1.9

—

Asthma, hospital admission 2, infections

139

1.90

2.53

4.4

—

Asthma-related infections

139

1.90

2.53

4.4

—

Myocardial infarction

3.09

2.47

1.1

1.8

—

Sleep disorders (combined)

137

0.38

2.47

3.4

3.1

—

Nail disorders

4.38

2.47

2.7

5.2

—

Continuous positive airway pressure

2.99

2.44

6.8

5.5

—

Symptoms and signs involving the nervous and musculoskeletal systems

116

1.98

2.44

3.3

4.6

—

Perforation of tympanic membrane

5.01

2.40

6.5

4.9

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

5.00

2.40

1.3

4.6

—

Nontraumatic intracranial haemmorrhage

5.00

2.40

2.8

2.3

—

Missing teeth due to accident, extraction or parodontitis

2.36

2.38

2.0

—

Hyperfunction of pituitary gland

6.26

2.37

3.0

4.6

—

Cerebral cysts

6.26

2.37

2.4

5.3

—

Other diseases of pancreas

6.26

2.37

1.2

3.0

—

Gout, strict definition

6.25

2.37

1.4

1.9

—

Adjustment and management of implanted device

6.25

2.37

1.0

4.8

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.08

2.37

2.3

3.2

—

Hard cardiovascular diseases

110

1.79

2.36

3.1

4.3

—

Injuries to the thorax

2.41

2.36

1.4

2.3

—

Impacted cerumen

4.12

2.36

6.1

5.1

—

Visual disturbances

2.09

2.32

4.0

4.3

—

Emotional disorders starting during childhood or adolescence

2.49

2.31

5.4

6.6

—

Embedded teeth, including avohilmo

3.22

2.30

3.0

4.4

—

Pain and other conditions associated with female genital organs and menstrual cycle

4.02

2.28

2.3

1.9

—

Other and unspecified iron deficiency

2.45

2.27

5.5

3.8

—

Conductive hearing loss, unspecified

3.89

2.25

5.9

4.7

—

Major coronary heart disease event excluding revascularizations

2.55

2.23

1.2

1.6

—

Scissor bite

2.54

2.22

8.2

6.3

—

Acne vulgaris

3.11

2.22

5.8

4.3

—

Phobic anxiety disorders

3.10

2.22

4.0

3.6

—

Juvenile osteochondrosis

5.57

2.21

4.6

4.4

—

Unspecified acute lower respiratory infection

2.86

2.20

4.4

3.4

—

Sleep disorders

122

0.36

2.19

3.0

2.7

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

3.21

2.18

1.4

1.8

—

Other disorders of glucose regulation and pancreatic internal secretion

3.34

2.18

2.3

5.7

—

Asthma-related pneumonia

2.12

2.17

4.4

5.1

—

Pain associated with micturition

4.29

2.15

4.2

5.9

—

Disorders of optic nerve and visual pathways

3.69

2.15

3.3

5.3

—

Diseases of male genital organs

1.80

2.14

4.7

4.8

—

Conjunctivitis (acute, non atopic)

2.02

2.13

4.6

5.1

—

Haemorrhage from respiratory passages

2.39

2.12

2.5

4.0

—

Asthma, hospital admissions 3, pneumonia

2.10

2.11

4.4

5.1

—

Asthma-related pneumonia or sepsis

2.10

2.11

4.4

5.1

—

Stroke, including SAH

2.27

2.10

1.7

1.6

—

Congenital stenosis of pulmonary valve

5.07

2.08

8.4

6.2

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

124

0.38

2.08

3.6

3.2

—

Triptan medication for migraine, single purchase ok

124

0.38

2.08

3.6

3.2

—

Polyarthropathies

1.86

2.07

2.5

3.6

—

Rosacea

5.00

2.07

4.4

2.3

—

Atrophic disorders of skin

5.00

2.07

5.4

4.1

—

Urticaria

2.07

2.06

6.8

4.4

—

Insomnia

120

0.36

2.06

3.0

2.4

—

Hyperkinetic disorders

2.03

2.05

6.8

5.9

—

Type 2 diabetes

1.95

2.04

1.3

1.7

—

Dermatitis and eczema

154

1.61

2.03

3.5

3.6

—

Isolated growth hormone deficiency

3.14

2.03

6.4

7.8

—

Hyperplasia of prostate

2.84

2.02

1.1

1.0

—

Chronic diseases of tonsils and adenoids

138

1.65

2.02

5.1

4.0

—

Congenital malformations of the circulatory system

1.96

1.99

6.1

6.2

—

DVT of lower extremities and pulmonary embolism

2.80

1.98

2.1

1.4

—

Other diseases of intestines

151

1.58

1.97

2.9

4.5

—

Cerebrovascular diseases

2.04

1.97

2.1

2.0

—

Percutaneous Coronary Intervention

102

1.74

1.96

3.0

4.3

—

Coronary revascularization (ANGIO or CABG)

102

1.74

1.96

3.0

4.3

—

Oral corticosteroids

1.85

1.94

2.3

2.1

—

Benign neoplasm of other and ill-defined parts of digestive system

4.55

1.94

1.0

1.7

—

Other diseases of intestine

4.55

1.94

1.0

2.9

—

Disorders of puberty, all

2.98

1.94

4.3

6.3

—

Early onset COPD, excluding more controls

4.54

1.94

1.0

1.1

—

Special screening examination for infectious and parasitic diseases

3.44

1.93

2.1

1.3

—

Congenital deformities of feet

3.76

1.93

5.0

5.5

—

Convergent concomitant strabismus

3.76

1.93

4.2

5.9

—

Other disorders of optic [2nd] nerve and visual pathways

3.76

1.93

3.5

5.6

—

Trigger finger

3.75

1.93

1.0

2.2

—

Other gastritis (incl. Duodenitis)

3.75

1.93

1.0

2.3

—

Female genital prolapse

3.60

1.92

1.9

1.3

—

Major coronary heart disease event

106

1.71

1.90

3.0

4.2

—

Congenital malformations of heart and great arteries

1.96

1.89

5.7

6.6

—

Autoimmune diseases related-to ILD

134

1.72

1.88

2.8

3.1

—

Cerebral palsy and other paralytic syndromes

3.18

1.88

3.1

4.4

—

Soft tissue disorders related to use, overuse and pressure

3.18

1.88

1.9

1.4

—

Specific developmental disorder of motor function

2.41

1.85

6.4

7.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.78

1.84

2.0

2.4

—

Disorders in reading

3.55

1.84

6.7

6.8

—

Pulmonary heart disease

3.53

1.83

2.7

1.5

—

Pulmonary embolism

3.53

1.83

2.7

1.5

—

Stroke, excluding SAH

2.26

1.82

1.8

1.7

—

Congenital deformities of feet

4.18

1.82

4.6

5.6

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.27

1.80

3.9

4.2

—

Pregnancy hypertension

2.60

1.80

1.0

1.5

—

Hypothyroidism, drug reimbursement

4.41

1.80

3.2

4.6

—

Other predominantly sexually transmitted diseases, not elsewhere classified

3.05

1.79

1.3

2.1

—

Urticaria and erythema

1.92

1.79

6.4

4.5

—

Functional dyspepsia

2.76

1.79

1.0

2.4

—

Emergency coronary revascularization (for ACS)

105

1.68

1.75

3.0

4.2

—

Codeine or tramadol medication

1.73

1.72

1.6

1.4

—

Visual impairment including blindness (binocular or monocular)

3.85

1.71

4.0

5.8

—

Dermatophytosis

3.85

1.71

3.2

2.8

—

Pre-eclampsia

3.85

1.71

1.0

1.6

—

Pre-eclampsia or eclampsia

3.85

1.71

1.0

1.6

—

Impacted teeth

2.08

1.69

6.5

4.6

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2.56

1.68

1.0

1.6

—

Abnormal findings on diagnostic imaging of lung

2.52

1.67

1.4

1.8

—

Sequelae of cerebrovascular disease

3.23

1.66

1.0

1.4

—

Mild mental retardation

3.17

1.66

6.8

5.3

—

Other and unspecified local infections of skin and subcutaneous tissue

3.16

1.66

5.2

4.8

—

Other local infections of skin and subcutaneous tissue

3.16

1.66

5.2

4.8

—

Caries of dentine, including avohilmo

1.68

1.66

4.0

4.9

—

Other soft tissue disorders, not elsewhere classified

126

1.58

1.65

4.0

—

Sleep apnoea, including avohilmo

109

0.45

1.64

2.8

2.2

—

Motor disorders

2.25

1.62

6.4

7.5

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.00

1.61

0.0

1.1

—

Artrosis, including avohilmo

0.41

1.60

1.8

1.5

—

Corneal ulcer

2.50

1.59

1.3

3.2

—

Urolithiasis

2.50

1.59

4.8

3.1

—

Ischemic heart diseases

107

1.63

1.59

3.1

4.1

—

Ischaemic Stroke, excluding all haemorrhages

2.27

1.58

1.5

1.8

—

Other disorders of lacrimal gland

2.33

1.58

2.9

2.6

—

Other systemic involvement of connective tissue

2.69

1.58

1.9

2.3

—

Other intervertebral disc disorders

0.39

1.56

1.4

—

Solid cancers, helper endpoint

1.76

1.56

3.0

3.2

—

Other disorders of ear

123

1.60

1.56

5.2

3.6

—

Lower back pain or/and sciatica

123

0.48

1.55

1.3

2.2

—

Low back pain

105

0.41

1.55

1.3

2.3

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.92

1.54

6.0

4.7

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.43

1.53

1.5

2.5

—

Intestinal stricture

2.42

1.53

1.0

3.1

—

Eustachian salpingitis and obstruction

3.34

1.52

5.0

3.0

—

Diabetes, insulin treatment (Kela reimbursement)

114

1.59

1.51

1.5

3.9

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

109

1.60

1.51

1.5

4.0

—

Heterophoria

2.86

1.50

5.8

6.5

—

Contact with and exposure to communicable diseases

100

1.79

1.50

4.4

5.0

—

Slow fetal growth and fetal malnutrition

2.88

1.50

5.0

6.6

—

Respiratory distress of newborn

2.08

1.47

5.7

7.0

—

Persons encountering health services in circumstances related to reproduction

129

1.57

1.46

4.4

4.6

—

Exposure to unspecified factor

173

1.50

1.46

2.9

4.2

—

Other disorders of eyelid

2.38

1.45

1.4

2.6

—

Superficial injury of ankle and foot

2.37

1.45

5.4

5.0

—

Cardiovascular disorders originating in the perinatal period

3.19

1.44

5.8

5.7

—

Acute lymphadenitis

3.13

1.44

6.2

5.1

—

Impacted maxillary molar

3.13

1.44

8.4

4.6

—

Ventral hernia

3.13

1.44

5.6

1.4

—

Degeneration of macula and posterior pole

2.53

1.43

1.3

2.1

—

Other systemic involvement of connective tissue (FG)

2.69

1.41

1.8

2.2

—

Other diseases of anus and rectum

2.25

1.39

2.9

3.3

—

Other diseases of pleura

2.19

1.39

2.0

3.4

—

Inflammatory diseases of female pelvic organs

2.05

1.38

1.7

1.9

—

Injury, poisoning and certain other consequences of external causes

1.70

1.37

4.6

5.1

—

Open wound of lower leg

2.20

1.36

1.6

4.4

—

Pulmonary heart disease, diseases of pulmonary circulation

2.61

1.36

2.7

2.2

—

Congenital malformations of pulmonary and tricuspid valves

2.97

1.36

8.4

7.1

—

Disorders of puberty

2.96

1.36

4.2

6.5

—

Other and unspecified injuries of lower leg

2.94

1.36

3.6

5.4

—

Non-selective monoamine reuptake inhibitors

0.00

1.34

0.0

1.4

—

Other dorsopathies, not elsewhere classified

118

0.53

1.34

3.0

2.9

—

Fracture of skull and facial bones

2.14

1.33

5.3

3.2

—

Biguanides

0.45

1.33

1.5

1.4

—

Myocardial infarction, strict

2.48

1.32

1.1

1.6

—

Disorders of eyelid, lacrimal system and orbit

108

1.62

1.32

2.7

3.3

—

Artificial joint operation, meniscal resection

0.43

1.31

1.5

1.6

—

Soft tissue disorders

134

1.46

1.31

4.1

—

Other specified congenital malformation syndromes affecting multiple systems

2.51

1.30

3.8

8.0

—

Fracture of shoulder and upper arm

1.81

1.30

2.5

4.4

—

Diagnoses used for exclusion with ILD

2.50

1.30

4.3

2.0

—

Basal cell carcinoma

2.60

1.30

1.0

2.0

—

Basal cell carcinoma, including avohilmo

2.58

1.29

1.0

2.0

—

Congenital deformities of hip

2.79

1.28

6.0

6.1

—

Congenital deformities of hip

2.79

1.28

6.0

6.1

—

Other disorders originating in the perinatal period

2.31

1.27

7.2

6.6

—

Fracture of femur

2.47

1.27

3.7

3.9

—

Other disorders of eye and adnexa

2.29

1.26

4.5

4.3

—

Colonic or urogenital fistula

2.29

1.26

3.1

1.8

—

Unstable angina pectoris

2.82

1.26

1.2

1.6

—

Finngen Rheumatological endpoints

113

1.51

1.24

2.7

3.4

—

Abnormalities of gait and mobility

2.40

1.24

3.2

5.1

—

Gastro-oesophageal reflux disease

1.69

1.24

2.1

3.7

—

Heart failure and bmi 25plus

2.81

1.24

1.0

1.6

—

Allergic rhinitis

118

0.42

1.23

2.4

5.4

—

Infections with a predominantly sexual mode of transmission

1.86

1.23

1.5

2.6

—

Adverse effects, not elsewhere classified

1.97

1.22

4.9

—

Allergic urticaria

2.63

1.21

7.8

6.1

—

Disorders of lacrimal system

1.96

1.21

2.7

3.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.42

1.20

1.0

1.9

—

Diverticular disease of intestine

1.89

1.19

1.2

1.3

—

Substance abuse, excluding more controls

1.85

1.19

1.5

1.6

—

Impetigo

2.31

1.18

5.5

6.3

—

Acute and subacute iridocyclitis

2.31

1.18

2.3

—

Other hearing loss

2.58

1.18

1.8

2.7

—

Diabetes mellitus

118

1.49

1.17

1.6

4.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

1.16

0.0

2.3

—

Foreign body on external eye

2.50

1.15

2.8

2.0

—

Other disorders of penis

2.05

1.15

7.6

5.3

—

Mixed specific developmental disorders

1.93

1.14

6.9

6.7

—

Disorders of conjunctiva

159

1.46

1.13

3.9

4.1

—

Conotruncal defects

2.35

1.12

7.7

6.7

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.75

1.12

3.7

4.7

—

Anterior Iridocyclitis

2.33

1.12

2.1

2.5

—

Transient ischemic attack

2.02

1.12

1.3

1.5

—

Mood disorders, excluding more controls

1.61

1.11

2.0

1.8

—

Other degenerative diseases of the nervous system

2.49

1.11

1.4

1.0

—

Malignant neoplasm of digestive organs

2.47

1.10

4.0

2.1

—

Other and unspecified effects of external causes

1.78

1.10

4.8

4.5

—

Right ventricular outflow tract obstruction

2.40

1.09

8.4

6.9

—

Diabetes medication

122

1.46

1.09

1.5

3.8

—

Hypoglycaemia, other or unspecified

2.38

1.09

1.8

6.0

—

Retinal detachments and breaks

2.38

1.09

2.2

1.4

—

Syncope and collapse

2.22

1.08

1.0

2.0

—

Conductive and sensorineural hearing loss

1.56

1.05

5.8

3.1

—

Abnormal involuntary movements

2.27

1.03

2.0

3.8

—

Early onset COPD

2.27

1.03

1.0

2.4

—

Myocardial infarction, without ST-elevation

2.28

1.02

1.2

1.5

—

Malignant neoplasm of breast

0.00

1.01

0.0

1.3

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.00

1.01

0.0

1.3

—

Malignant neoplasm of breast, including Hilmo

0.00

1.01

0.0

1.3

—

Disorders of speech understanding and production

1.89

1.01

8.3

7.0

—

Abnormal findings on examination of blood, without diagnosis

1.69

1.00

3.7

3.4

—

Premature rupture of membranes

0.00

1.00

0.0

1.4

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

2.00

1.00

3.3

6.0

—

Iridocyclitis

2.00

1.00

2.1

3.0

—

Conjunctivitis

157

1.44

0.98

4.1

4.2

—

Congenital malformations of the respiratory system

2.18

0.98

4.8

5.9

—

Congenital malformations of the respiratory system

2.18

0.98

4.8

5.9

—

Panic disorder

2.17

0.98

3.0

2.3

—

Follicular cysts of skin and subcutaneous tissue

2.17

0.98

2.2

2.5

—

Hydrocele

2.17

0.98

6.2

4.6

—

Diabetes, varying definitions

119

1.43

0.97

1.7

4.0

—

Hypothyroidism, other/unspecified

1.52

0.96

2.1

2.9

—

COPD related to multimorbidity

2.30

0.95

1.0

1.6

—

Atopic dermatitis, strict definition with reimbursement

1.59

0.94

5.1

—

Paracetamol or NSAID medication

0.46

0.94

3.2

5.7

—

Neurological diseases

128

1.37

0.93

3.7

4.8

—

Spondylopathies

0.52

0.91

1.3

1.8

—

Ovarian cyst

2.16

0.91

1.5

1.6

—

Angina pectoris

1.97

0.91

1.1

1.4

—

Exclusion endpoint for clefts

2.07

0.89

3.8

7.4

—

Fissure and fistula of anal and rectal regions

2.07

0.89

3.0

1.7

—

Personality disorders, excluding more controls

2.07

0.89

1.8

1.5

—

Non-invasive ventilation

2.06

0.88

6.0

4.2

—

Menorrhagia

2.08

0.88

3.5

1.6

—

Malignant neoplasm of skin

2.06

0.88

1.0

1.9

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.48

0.87

2.1

2.9

—

Organic, including symptomatic, mental disorders

2.03

0.87

1.2

1.6

—

Mycoses

147

1.42

0.85

3.8

3.2

—

1.55

0.81

2.1

2.2

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.81

0.0

1.6

—

Single delivery by forceps and vacuum extractor

0.00

0.81

0.0

1.7

—

Gonarthrosis,primary

0.50

0.81

1.0

1.3

—

Non-rheumatic valve diseases

1.66

0.81

3.8

4.0

—

Depression

127

1.39

0.80

2.0

3.0

—

Prolonged pregnancy

0.00

0.80

0.0

1.7

—

Other sexually transmitted chlamydial diseases

0.00

0.79

0.0

2.4

—

Combinations of oral blood glucose lowering drugs

0.00

0.79

0.0

1.4

—

Cardiodefibrillation

0.00

0.79

0.0

2.2

—

Malignant neoplasm of breast, HER2-negative

0.00

0.79

0.0

1.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.51

0.79

1.9

2.6

—

Lumbar disc prolapse

0.50

0.79

1.4

—

Autism spe

0.00

0.78

0.0

5.8

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.67

0.78

5.5

3.8

—

Dorsalgia

114

0.66

0.77

2.6

2.9

—

Mental and behavioural disorders due to alcohol

1.58

0.77

2.0

2.3

—

Mood [affective] disorders

128

1.37

0.76

2.0

3.0

—

Mood disorders

128

1.36

0.76

2.0

3.0

—

Pain in throat and chest

1.42

0.76

3.5

2.8

—

Bacterial sepsis of newborn

2.11

0.75

8.4

6.9

—

Dysphagia

2.08

0.74

3.8

2.2

—

Transport accidents

1.52

0.74

3.4

3.7

—

Dorsopathies

137

0.70

0.74

2.9

3.5

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.84

0.73

4.6

7.1

—

Other and unspecified urticaria

1.64

0.73

6.1

4.6

—

Fracture of foot, except ankle

1.64

0.73

5.4

3.5

—

Polyp of the female genital tract

2.05

0.73

1.6

—

Mental retardation, wide definition

1.63

0.73

6.8

7.3

—

Benign neoplasm of colon, rectum, anus and anal canal

1.63

0.73

1.1

1.3

—

Mental retardation

1.63

0.73

6.8

7.3

—

Injuries to the elbow and forearm

139

1.39

0.72

3.6

4.2

—

Aortic valve malfunction, age under 60 years

2.00

0.72

2.6

5.3

—

Other diseases of the respiratory system

2.00

0.72

2.2

4.6

—

Other respiratory disorders and diseases

2.00

0.72

2.2

4.6

—

Paralytic ileus and intestinal obstruction

2.00

0.72

1.0

2.5

—

Acute alcohol intoxication

1.80

0.72

2.9

2.6

—

Other congenital malformations

1.61

0.72

4.7

6.8

—

Valvular heart disease excluding rheumatic fever

1.56

0.71

5.4

4.4

—

Weight loss

1.92

0.70

8.0

5.0

—

Asthma, hospital admissions , main diagnosis only

171

1.34

0.70

4.0

3.9

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.89

0.69

1.4

1.2

—

Undescended testicle

1.86

0.68

8.2

6.9

—

5-aminosalicylic acid

1.85

0.68

5.0

3.1

—

Disorders of the thyroid gland

104

1.38

0.67

2.1

2.7

—

Other specified/unspecified arthritis

1.63

0.66

3.4

3.7

—

Fall on same level involving ice and snow

0.54

0.66

3.0

—

Benign paroxysmal vertigo

1.79

0.66

1.2

2.2

—

Calculus of kidney and ureter

1.79

0.66

7.0

3.0

—

Pre-eclampsia or poor fetal growth

1.78

0.66

1.0

1.5

—

1.49

0.65

1.9

2.1

—

Sleep apnoea

101

0.64

0.65

2.6

2.2

—

Cholelithiasis, broad definition with cholecystitis

1.50

0.64

2.4

1.7

—

Myopia

1.72

0.64

6.0

4.3

—

Atopic dermatitis, strict definition

118

1.41

0.63

5.2

5.0

—

Other arthritis (FG)

1.63

0.62

3.5

3.4

—

Other disorders of veins

1.66

0.61

1.0

1.4

—

Allergic contact dermatitis

0.00

0.60

0.0

3.7

—

Other disorders of patella

0.00

0.59

0.0

1.8

—

Dental pulpitis, including avohilmo

129

0.70

0.59

1.6

3.0

—

Congenital malformations of genital organs

1.53

0.59

6.8

—

Gonarthrosis [arthrosis of knee](FG)

0.56

0.58

1.0

1.3

—

Other/unspecified dorsalgia

1.50

0.57

3.5

2.7

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

112

0.61

0.57

4.7

4.2

—

Non-allergic asthma

1.71

0.57

4.5

6.5

—

Other chronic obstructive pulmonary disease

1.70

0.57

1.0

2.2

—

External causes of morbidity and mortality

1.34

0.57

4.5

4.7

—

COPD, hospital admissions

1.69

0.57

1.0

2.0

—

Childhood allergy (age < 16)

1.40

0.57

5.0

5.9

—

Congenital malformations of eye, ear, face and neck

1.67

0.56

4.5

6.8

—

COPD, early/later onset

1.63

0.55

1.0

2.0

—

Acute alcohol intoxication, ICD10

1.62

0.55

3.0

2.6

—

Infections specific to the perinatal period

1.59

0.54

8.3

7.1

—

Effects of foreign body entering through natural orifice

1.50

0.54

4.6

4.5

—

Allergic colitis

1.54

0.53

8.7

6.5

—

Leisure time condition

1.54

0.53

5.5

3.7

—

Other congenital malformations

1.45

0.53

4.7

6.5

—

Pain in joint

1.41

0.53

2.7

3.6

—

Other arthrosis

1.54

0.52

1.6

1.4

—

COPD

1.53

0.52

1.0

2.2

—

Fracture of forearm

1.39

0.52

2.7

4.2

—

Type of accident

1.43

0.52

6.1

3.6

—

Type 1 diabetes, definitions combined

1.43

0.52

2.3

6.4

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

0.62

0.52

6.5

3.9

—

Type 1 diabetes, strict (exclude DM2)

1.40

0.51

2.3

6.3

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.40

0.51

1.1

1.7

—

Type 2 diabetes, definitions combined, including avohilmo

0.65

0.50

1.6

—

Injuries to the ankle and foot

159

1.29

0.50

5.1

3.6

—

Excessive earwax

1.39

0.50

6.1

3.6

—

Fracture of lower leg, including ankle

1.41

0.50

3.3

3.5

—

Abrasion of teeth

1.46

0.50

1.2

2.3

—

Use of hypnotics and sedatives

107

1.29

0.50

1.8

3.0

—

Abnormalities of heart beat

1.56

0.49

3.1

2.8

—

Disorders of breast

1.55

0.49

1.9

1.8

—

Dislocation, sprain and strain of joints and ligaments of knee

102

0.63

0.48

2.6

—

Vasomotor and allergic rhinitis

109

0.63

0.48

2.6

4.7

—

Sensorineural hearing loss

1.36

0.48

5.8

2.8

—

Redundant prepuce, phimosis and paraphimosis

1.51

0.48

6.6

4.5

—

Fracture at wrist and hand level

0.62

0.45

2.6

4.1

—

Obesity due to excess calories

0.61

0.45

1.8

3.8

—

Mental and behavioural disorders due to psychoactive substance use

1.37

0.45

1.9

2.3

—

Other symptoms and signs involving cognitive functions and awareness

1.39

0.44

1.7

2.2

—

Postmenopausal atrophic vaginitis

0.00

0.43

0.0

1.3

—

Other arrhythmias

1.39

0.42

1.5

3.1

—

Substance abuse

1.36

0.41

1.5

2.4

—

Congenital malformations of cardiac chambers and connections

0.00

0.41

0.0

7.0

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.41

0.0

5.8

—

Ethmoidectomy

0.00

0.41

0.0

2.6

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.41

0.0

3.6

—

Assault by bodily force

0.00

0.41

0.0

2.4

—

Primary coxarthrosis, bilateral

0.00

0.41

0.0

1.5

—

Type 2 diabetes, strict (exclude DM1)

0.67

0.41

1.6

1.5

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.40

0.0

6.8

—

Appendectomy

1.35

0.40

3.0

2.0

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

0.40

0.0

2.3

—

Unspecific neurodegenerative disorder

0.00

0.40

0.0

1.1

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.33

0.40

7.1

—

Cholelithiasis

1.38

0.40

2.4

1.7

—

Malignant neoplasm of breast, HER-positive

0.00

0.40

0.0

1.2

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

0.39

0.0

1.2

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.31

0.39

7.1

6.9

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.39

0.0

6.6

—

Dyspnoea

124

1.25

0.39

1.8

3.8

—

D07AA Corticosteroids, weak (group I)

1.41

0.39

3.9

6.1

—

Irritable bowel syndrome

1.39

0.38

1.0

3.1

—

Arthropathies

131

1.20

0.37

3.1

4.2

—

Gonarthrosis

0.62

0.37

1.0

1.2

—

Cholecystectomy

1.29

0.37

2.1

1.5

—

Open wound of wrist and hand

1.32

0.36

1.4

3.5

—

Personality disorders

1.43

0.35

1.8

1.9

—

Benign neoplasm: Colon

1.40

0.35

1.2

1.3

—

Appendicitis, broad definition

106

1.28

0.34

2.2

2.0

—

Other functional intestinal disorders

109

1.28

0.34

4.5

5.4

—

Obesity, other/unspecified

1.33

0.33

1.8

2.8

—

Diseases of appendix

106

1.28

0.33

2.2

2.0

—

Injuries to the knee and lower leg

151

1.18

0.33

2.7

3.8

—

Diseases of liver

1.30

0.33

2.2

2.7

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.30

0.33

1.7

1.2

—

Type 2 diabetes, definitions combined

0.68

0.31

1.6

1.5

—

Congenital malformations of cardiac septa

1.35

0.31

4.4

7.2

—

Allergic conjunctivitis

128

0.76

0.31

5.7

4.0

—

Necrosis of pulp, including avohilmo

0.71

0.30

1.1

2.4

—

Cardiac arrhythmias

1.25

0.30

2.1

4.2

—

Diseases of inner ear

1.30

0.30

1.3

1.8

—

Constipation

151

0.82

0.29

3.3

4.3

—

Injuries to the wrist and hand

166

1.17

0.29

1.7

4.1

—

Falls/tendency to fall

158

0.86

0.29

4.5

3.9

—

Other joint disorders

121

0.83

0.29

2.8

4.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.23

0.29

1.7

1.6

—

Chronic apical periodontitis

110

1.19

0.28

1.3

3.0

—

Alcohol use disorder, Swedish definition

1.29

0.27

1.5

1.8

—

Behavioural syndromes associated with physiological disturbances and physical factors

145

0.83

0.26

3.4

3.2

—

Inflammatory bowel disease

1.19

0.26

3.6

3.7

—

Episodal and paroxysmal disorders

164

0.87

0.26

3.3

4.2

—

Meniscus derangement

1.21

0.25

1.9

1.2

—

Haemorrhagic and haematological disorders of fetus and newborn

1.20

0.25

5.7

6.8

—

Selective serotonin reuptake inhibitors

123

0.85

0.24

2.1

3.1

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.32

0.23

5.0

3.0

—

Specific personality disorders

1.32

0.23

1.8

1.7

—

Injuries to the head

174

1.13

0.23

3.5

3.9

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

0.76

0.22

3.7

2.6

—

Atopic dermatitis

125

1.18

0.22

5.1

4.2

—

Atrial septal defect

1.24

0.22

3.6

6.8

—

Fall on and from stairs and steps

1.22

0.22

6.2

3.4

—

Shoulder lesions

1.26

0.22

1.1

1.3

—

Postpartum care and examination

0.00

0.22

0.0

1.3

—

Disorders of vestibular function (Vertigo)

1.20

0.21

1.2

1.9

—

Congenital malformations of larynx

0.00

0.21

0.0

4.9

—

AV-block

0.00

0.21

0.0

4.6

—

Other congenital malformations of skull and face bones

0.00

0.21

0.0

5.5

—

Malignant neoplasm of breast, ER-negative, including Hilmo

0.00

0.21

0.0

1.2

—

Alzheimer disease, including avohilmo

0.00

0.21

0.0

1.1

—

Complex cardiac defects

0.00

0.21

0.0

6.8

—

Malignant neoplasm of breast, HER-negative

0.00

0.21

0.0

1.2

—

Disorder of the sleep-wake schedule

0.00

0.21

0.0

5.9

—

Bicuspidal aortic valve syndrome

0.00

0.21

0.0

5.5

—

Burn and corrosion of wrist and hand

0.00

0.21

0.0

4.8

—

Other and unspecified injuries of wrist and hand

0.00

0.21

0.0

6.5

—

Foreign body in alimentary tract

0.00

0.21

0.0

5.1

—

Other sexually transmitted chlamydial diseases

0.00

0.21

0.0

2.6

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

3.0

—

Injury of muscle and tendon at hip and thigh level

0.00

0.21

0.0

4.9

—

Metatarsalgia

0.00

0.21

0.0

2.3

—

Psoriatic arthropathies

0.00

0.21

0.0

1.6

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.21

0.0

2.3

—

Cervicocranial syndrome

0.00

0.21

0.0

2.2

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.21

0.0

1.6

—

L02BA Anti-estrogens

0.00

0.21

0.0

1.2

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.21

0.0

1.2

—

Use of anticholinesterases

0.00

0.21

0.0

1.1

—

N06DA Anticholinesterases

0.00

0.21

0.0

1.1

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.21

0.0

1.5

—

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

0.21

0.0

5.8

—

Autism spe, excluding more controls

0.00

0.21

0.0

6.3

—

Injury of unspecified body region

0.00

0.21

0.0

4.5

—

Recurrent dislocation and subluxation of joint

0.00

0.21

0.0

2.7

—

Retained placenta and membranes, without haemorrhage

0.00

0.21

0.0

1.2

—

Psoriatic and enteropathic arthropathies

0.00

0.21

0.0

1.6

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.21

0.0

2.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.21

0.0

1.6

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.21

0.0

1.6

—

Polyarthrosis

0.00

0.21

0.0

1.7

—

Enterobiasis

0.00

0.21

0.0

7.0

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

0.21

0.0

3.7

—

Crohn disease (strict definition, require KELA)

0.00

0.21

0.0

3.7

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.21

0.0

3.7

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.21

0.0

4.3

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.21

0.0

2.3

—

Other eating disorders

0.00

0.21

0.0

5.0

—

Acute and transient psychotic disorders

0.00

0.21

0.0

1.5

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

124

1.15

0.20

2.3

2.7

—

Liveborn infants according to place of birth

0.00

0.20

0.0

6.1

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.20

0.0

6.6

—

Major anomalies of jaw size

0.00

0.20

0.0

5.8

—

FESS (DNB20)

0.00

0.20

0.0

2.7

—

Radiculopathy

0.00

0.20

0.0

1.6

—

Lichen planus, including avohilmo

0.00

0.20

0.0

1.6

—

Other disorders of amniotic fluid and membranes

0.00

0.20

0.0

1.3

—

Obesity and other hyperalimentation

107

0.81

0.20

1.9

3.4

—

Obesity

107

0.81

0.20

1.9

3.4

—

Disorders of adult personality and behaviour

1.22

0.20

2.8

2.3

—

Congenital malformations of great arteries

1.16

0.19

4.3

7.3

—

Ulcerative colitis

1.15

0.19

4.5

3.5

—

Exposure to other specified factors

169

1.14

0.18

2.2

3.8

—

Other diseases of upper respiratory tract

145

1.11

0.18

4.7

3.8

—

Carpal tunnel syndrome

1.21

0.18

1.3

1.4

—

Acute appendicitis

102

1.19

0.18

1.8

2.0

—

Intracranial injury

134

0.85

0.17

4.3

4.4

—

Alcohol use disorder, ICD-based

1.11

0.17

1.1

1.7

—

Rotator cuff syndrome

1.20

0.17

1.1

1.2

—

Focal epilepsy

1.16

0.16

4.4

5.0

—

Injuries to the hip and thigh

1.11

0.16

3.3

3.8

—

Temporomandibular joint disorders, including avohilmo

1.10

0.15

1.7

2.4

—

Septal defects

1.14

0.15

4.8

7.0

—

Diseases of pulp and periapical tissues, including avohilmo

138

0.90

0.15

2.0

4.3

—

Benzodiazepine use

118

0.87

0.14

1.8

2.2

—

Open wound of head

136

1.13

0.13

4.4

4.3

—

Asthma/COPD (KELA code 203)

166

0.91

0.12

4.0

3.8

—

Other antidepressants

102

0.90

0.10

2.1

2.3

—

Exclusions for E4_PCOS_CONSORTIUM

114

1.10

0.10

5.0

4.1

—

Migraine

101

0.88

0.09

3.0

4.1

—

Other chronic obstructive pulmonary disease, including avohilmo

1.13

0.09

1.0

1.8

—

Acute appendicitis, no complications

1.14

0.09

2.0

—

Leiomyoma of uterus

1.06

0.09

1.0

1.3

—

Dizziness and giddiness

0.88

0.08

2.2

2.6

—

Internal derangement of knee

1.07

0.08

2.0

2.2

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.04

0.08

1.3

1.2

—

Medical abortion

1.12

0.08

1.6

1.8

—

Striking against or struck by other objects

107

1.12

0.08

2.5

4.7

—

Superficial injury of lower leg

0.81

0.08

2.0

3.8

—

Dermatitis due to ingested food

0.77

0.08

5.8

6.8

—

Deforming dorsopathies

1.06

0.08

2.3

4.0

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.03

0.08

8.9

6.8

—

Other (not insulin) diabetes medications

0.89

0.07

1.6

1.5

—

Periapical abscess

1.05

0.07

1.7

3.4

—

Reimbursement for rheumatic diseases

0.87

0.06

4.4

3.8

—

Other specific joint derangements/joint disorders

112

0.92

0.06

2.5

3.7

—

Fall on same level

172

0.95

0.06

4.2

3.9

—

Asthma (diagnoses ohter than nonallergic)

172

1.06

0.05

4.0

—

Accidents

111

0.95

0.04

3.7

4.1

—

Other external causes of accidental injury

111

0.95

0.04

3.7

4.1

—

Injuries to the shoulder and upper arm

145

0.94

0.04

2.4

3.4

—

Other nutritional deficiencies

112

0.92

0.03

2.2

3.4

—

Intracranial trauma

105

0.94

0.03

3.8

4.9

—

Asthma, including avohilmo

173

0.97

0.01

3.7

3.8

—

Epilepsy

1.06

0.00

4.2

5.3

—

Depression or dysthymia

1.04

0.00

3.2

2.1

—

Concussion

104

1.02

0.00

3.9

4.8

—

Unspecified fall

128

1.00

0.00

5.3

4.8

—

Dermatophytosis

105

0.95

0.00

2.5

2.9

—

Chronic lower respiratory diseases

169

1.01

0.00

3.6

3.8

—

Benign neoplasm of middle ear and respiratory system

0.00

0.0

3.2

—

Lactose intolerance

0.00

0.0

4.8

—

Infections of genitourinary tract in pregnancy

0.00

0.0

1.1

—

Use of memantine

0.00

0.0

1.1

—

Other disorders of pigmentation

0.00

0.0

4.6

—

Burns classified according to extent of body surface involved

0.00

0.0

3.7

—

Parkinson's disease, including avohilmo

0.00

0.0

1.0

—

Nummular dermatitis

0.00

0.0

2.6

—

Other bursopathies

0.00

0.0

2.6

—

Use of other anti-dementia drugs

0.00

0.0

1.1

—

Twin gestation

0.00

0.0

1.3

—

Benign mammary dysplasia

0.00

0.0

1.1

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.2

—

0.00

0.0

2.2

—

Struck by thrown, projected or falling objec

0.00

0.0

5.5

—

Psoriatic arthropathies, ICD10

0.00

0.0

1.9

—

Certain zoonotic bacterial diseases

0.00

0.0

3.6

—

Alzheimer’s disease (Late onset)

0.00

0.0

1.0

—

Colorectal adenocarcinoma

0.00

0.0

2.3

—

Sudden idiopathic hearing loss

0.00

0.0

2.0

—

Digestive system disorders of fetus and newborn

0.00

0.0

6.3

—

Benign neoplasm: Skin of scalp and neck

0.00

-0.00

0.0

6.2

—

Multiple gestation

0.00

-0.00

0.0

1.3

—

Congenital malformations of lung

0.00

-0.00

0.0

4.8

—

L04AC Interleukin inhibitors

0.00

-0.00

0.0

4.9

—

L02BB Anti-androgens

0.00

-0.00

0.0

1.0

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

5.4

—

Microcephaly

0.00

-0.00

0.0

4.6

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

4.8

—

Congenital malformations of great veins

0.00

-0.00

0.0

6.3

—

Other headache syndromes

1.00

-0.00

1.0

2.4

—

Other psoriatic arthropathies

0.00

-0.00

0.0

2.2

—

Congenital malformations of lung

0.00

-0.00

0.0

4.8

—

Other osteochondrodysplasias

0.00

-0.00

0.0

5.6

—

Use of levodopa decarboxylase inhibitor

0.00

-0.00

0.0

1.0

—

Recurrent or chronic depression

0.88

-0.00

1.6

1.8

—

Aortic hypoplasia

0.00

-0.00

0.0

5.8

—

Multiple delivery

0.00

-0.00

0.0

1.3

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

5.0

—

Other osteochondrodysplasias

0.00

-0.00

0.0

5.6

—

Other perinatal digestive system disorders

0.00

-0.00

0.0

6.0

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

6.8

—

Poor fetal growth

0.00

-0.00

0.0

1.7

—

Other perinatal haematological disorders

0.00

-0.00

0.0

5.4

—

0.00

-0.00

0.0

6.1

—

Single ventricle heart

0.00

-0.00

0.0

7.6

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

6.0

—

Neonatal jaundice from other and unspecified causes

0.95

-0.00

4.7

7.0

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

-0.00

0.0

1.0

—

Other puerperal infections

0.00

-0.00

0.0

1.1

—

Pregnancy with abortive outcome

1.01

-0.00

1.3

1.8

—

Unspecified jaundice

0.00

-0.00

0.0

5.0

—

Other symptoms and signs involving general sensations and perceptions

0.00

-0.00

0.0

3.4

—

Sequelae of injuries of lower limb

0.00

-0.00

0.0

2.2

—

Down's syndrome

0.00

-0.00

0.0

4.9

—

Toxic effect of contact with venomous animals

0.00

-0.00

0.0

5.4

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

1.9

—

Other obstructed labour

0.00

-0.00

0.0

1.3

—

Injury of intra-abdominal organs

0.00

-0.00

0.0

4.7

—

Uterine polyps

0.00

-0.00

0.0

1.2

—

Failed induction of labour

0.00

-0.00

0.0

1.9

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.88

-0.00

1.0

3.7

—

Obesity related asthma

0.94

-0.00

2.6

3.2

—

Lichen planus

0.00

-0.00

0.0

2.0

—

Arthrosis

0.95

-0.00

1.6

1.4

—

Polycystic ovarian syndrome, broad definition

0.00

-0.00

0.0

1.6

—

Maxillary prognathism

0.00

-0.00

0.0

4.9

—

Thiazolidinediones

0.00

-0.00

0.0

2.2

—

Chronic laryngitis and laryngotracheitis

0.00

-0.00

0.0

1.9

—

Benign neoplasm of meninges

0.00

-0.00

0.0

1.8

—

Fibrosis and cirrhosis of liver

0.00

-0.00

0.0

2.3

—

Open wound of hip and thigh

0.00

-0.00

0.0

4.2

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

2.2

—

Inflammatory bowel disease, strict (require KELA)

0.91

-0.00

5.0

3.4

—

Ovarian dysfunction

0.00

-0.00

0.0

1.6

—

Disorder of visual pathways, unspecified

0.00

-0.00

0.0

5.8

—

Malignant neoplasm of endocrine gland

0.00

-0.00

0.0

4.3

—

Ulcerative proctitis

0.00

-0.00

0.0

3.4

—

Alzheimer’s disease, strict definition

0.00

-0.00

0.0

1.1

—

Foreign body or object entering through skin

0.00

-0.00

0.0

3.9

—

Wet age-related macular degeneration

0.00

-0.00

0.0

1.0

—

Nonalcoholic fatty liver disease

0.00

-0.00

0.0

2.9

—

Other fall from one level to another

0.96

-0.00

3.8

5.6

—

Other and unspecified visual disturbances

0.00

-0.00

0.0

3.3

—

Intentional self-harm by sharp object

0.00

-0.00

0.0

4.4

—

Motorcycle rider injured in noncollision transport accidents

0.00

-0.00

0.0

3.5

—

Malignant neoplasm of adrenal gland, including Hilmo

0.00

-0.00

0.0

6.2

—

Operations 1 for CAVS

0.00

-0.00

0.0

8.0

—

Memory loss

0.00

-0.00

0.0

1.0

—

Parkinson's disease

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in transport accident

0.85

-0.00

5.4

4.2

—

Lactose intolerance, other/unspecified

0.00

-0.00

0.0

4.8

—

Alzheimer disease

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Cerebral meninges

0.00

-0.00

0.0

1.8

—

Focal epilepsy, strict definition

0.97

-0.00

4.3

4.9

—

Other congenital malformations of face and neck

0.00

-0.00

0.0

4.2

—

Raynaud syndrome

0.00

-0.00

0.0

1.8

—

Phakomatoses, not elsewhere classified

0.00

-0.00

0.0

6.3

—

Sleep disorders, other/unspecified

0.00

-0.00

0.0

3.8

—

Migraine without aura

0.85

-0.00

3.8

4.6

—

Rheumatism, unspecified

0.00

-0.00

0.0

1.0

—

Muscular dystrophy

0.00

-0.00

0.0

7.0

—

Constitutional tall stature

0.00

-0.00

0.0

4.9

—

Other obstetric trauma

0.00

-0.00

0.0

1.1

—

Transient global amnesia

0.00

-0.00

0.0

1.0

—

Entropion and trichiasis of eyelid

0.00

-0.00

0.0

2.0

—

Residual foreign body in soft tissue

0.00

-0.00

0.0

5.2

—

Parkinson's disease, strict definition, excluding more controls

0.00

-0.00

0.0

1.0

—

Alzheimer disease, excluding more controls

0.00

-0.00

0.0

1.0

—

Parkinson's disease, excluding more controls

0.00

-0.00

0.0

1.0

—

Alcoholic liver disease

0.00

-0.00

0.0

2.0

—

Chronic sinusitis

0.91

-0.00

3.0

2.1

—

Varicose veins of other sites

0.00

-0.00

0.0

3.2

—

Spermatocele

0.00

-0.00

0.0

2.3

—

Other respiratory conditions originating in the perinatal period

0.00

-0.00

0.0

5.1

—

Polymyalgia rheumatica

0.00

-0.00

0.0

1.0

—

Other congenital malformations of peripheral vascular system

0.00

-0.00

0.0

4.3

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

-0.00

0.0

1.0

—

Unspecified event, undetermined intent

0.00

-0.00

0.0

5.2

—

IBD patients in KELA-register

1.02

-0.00

5.0

3.3

—

Benign neoplasm of eye and adnexa

0.00

-0.00

0.0

1.9

—

Lichen simplex chronicus and prurigo

0.00

-0.00

0.0

3.0

—

Type1 diabetes, definitions combined, early onset

0.96

-0.00

3.0

6.3

—

Scabies

0.91

-0.00

5.6

4.8

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

0.00

-0.00

0.0

4.6

—

Use of rivastigmine

0.00

-0.00

0.0

1.0

—

Other/unspecified rheumatoid arthritis

0.00

-0.00

0.0

1.0

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

0.00

-0.00

0.0

6.2

—

Gender identity disorders

0.00

-0.00

0.0

4.6

—

Amiodarone users

0.00

-0.00

0.0

2.2

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

-0.00

0.0

3.6

—

Parkinson's disease, strict definition

0.00

-0.00

0.0

1.0

—

Abnormal spermatozoa

0.00

-0.00

0.0

1.9

—

Other pulmonary heart/vessel disease

0.00

-0.00

0.0

3.9

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

0.97

-0.00

1.3

3.9

—

Open wound of abdomen, lower back and pelvis

0.00

-0.00

0.0

4.8

—

Pediculosis, acariasis and other infestations

0.85

-0.00

5.6

4.7

—

Congenital aortic valve stenosis

0.00

-0.00

0.0

6.1

—

Rubella [German measles]

0.00

-0.00

0.0

1.0

—

Use of donepezil

0.00

-0.00

0.0

1.0

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS